Compound ID 324   (prev - next)

Name: Silymarin (31553) (edit)

10 entries:
TreatmentSilymarinphysical functionphysiological functionlifespanTranscriptomeProteomeMetabolomeTargetReferenceblinded
CID (PubChem)31553ChEMBLlocomotion on solid mediaheat stress resistanceoxidative stress resistancemean lifespan
ConcentrationExposure timeFoodGrowth mediumSpecial additivesC. elegans strainTemperatureChange compared to controlPercentual change compared to controlp < 0.05notesChange compared to controlPercentual change compared to controlp < 0.05notesChange compared to controlPercentual change compared to controlp < 0.05notesChange compared to controlPercentual change compared to controlp < 0.05notes
10 µMwhole life; start: parental generationOP50, UV-inactivatedNGM agarN2 (wild type)20°Cup4.55yesFilippopoulou K, Papaevgeniou N, Lefaki M, Paraskevopoulou A, Biedermann D, Křen V, Chondrogianni N (2017) 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radic Biol Med 103, 256-267.
50 µMwhole life; start: parental generationOP50, UV-inactivatedNGM agarN2 (wild type)20°Cup13.64yesFilippopoulou K, Papaevgeniou N, Lefaki M, Paraskevopoulou A, Biedermann D, Křen V, Chondrogianni N (2017) 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radic Biol Med 103, 256-267.
25 µMwhole life; start: L4OP50NGM agarN2 (wild type)20°Cup44.85yesA10; endpoint: spontaneous movement; no significant change in number of body bends at A5up23.59yesA5: stressor: 35°C for 4 h; endpoint: survivalup10.08yesKumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302.
50 µMwhole life; start: L4OP50NGM agarN2 (wild type)20°Cup82.47yesA10; endpoint: spontaneous movement; significantly increased number of body bends at A5 (+29.47%)up42.21yesA5: stressor: 35°C for 4 h; endpoint: survivalup24.80yesKumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302.
100 µMwhole life; start: L4OP50NGM agarN2 (wild type)20°Cdown-25.26yesA10; endpoint: spontaneous movement; no significant change in number of body bends at A5down-25.76yesA5: stressor: 35°C for 4 h; endpoint: survivaldown-8.95yesKumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302.
25 µMwhole life; start: L4OP50NGM agarCL4176 {smg-1(cc546); dvIs27 [myo-3p::A-Beta (1-42)::let-851 3'UTR) + rol-6(su1006)]}16°Cupyespre-exposed to 25°C for 18-20 h; endpoint: ratio of non-paralyzed and paralyzed wormsKumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302.
50 µMwhole life; start: L4OP50NGM agarCL4176 {smg-1(cc546); dvIs27 [myo-3p::A-Beta (1-42)::let-851 3'UTR) + rol-6(su1006)]}16°Cupyespre-exposed to 25°C for 18-20 h; endpoint: ratio of non-paralyzed and paralyzed wormsupyespre-exposed to 25°C; stressor: 10 mM paraquat; endpoint: motilityKumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302.